Laurion Capital Management »

Aardvark Therapeutics shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Aardvark Therapeutics (AARD) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Aardvark Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aardvark Therapeutics held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aardvark Therapeutics by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $14M 1.0M 13.29
2025-06-30 $13M 989k 13.52
2025-03-31 $6.1M 808k 7.51

More positions owned by Laurion Capital Management

Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Apple Call Option (AAPL)
Abbvie Put Option (ABBV)
Blackrock (BLK)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Goldman Sachs (GS)
Alphabet Cap Stk Cl C (GOOG)
Texas Instruments Incorporated (TXN)
JPMorgan Chase & Co. (JPM)
Meta Platforms Cl A (META)
Strategy Cl A New Call Option (MSTR)
International Business Machines (IBM)
NVIDIA Corporation Call Option (NVDA)
Honeywell International (HON)

View all positions for Laurion Capital Management

Top funds holding Aardvark Therapeutics

Decheng Capital
Citadel Advisors
Laurion Capital Management
Vanguard Group
Adage Capital Partners GP
Millennium Management
BlackRock
Silverarc Capital Management
Schonfeld Strategic Advisors
Geode Capital Management
Cresset Asset Management
Cantor Fitzgerald, L. P.
State Street Corporation
Two Sigma Investments
Northern Trust

View all funds holding Aardvark Therapeutics